(Q42242848)

English

Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses

scientific article published on 13 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Simona Gallorini

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Marianna Taccone

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Alessandra Bonci

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Filomena Nardelli

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Daniele Casini

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Amanda Bonificio

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sushma Kommareddy

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sylvie Bertholet

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Derek T O'Hagan

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Barbara C Baudner

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

13 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2382-2388

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Serious morbidity and mortality associated with influenza epidemics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Needle-free influenza vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Novel approaches to vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Influencing the fates of CD4 T cells on the path to memory: lessons from influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Persistence of mucosal and systemic immune responses following sublingual immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Vaccines for mucosal immunity to combat emerging infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Sublingual vaccination with influenza virus protects mice against lethal viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Sublingual immunization induces broad-based systemic and mucosal immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Preparation of highly concentrated influenza vaccine for use in novel delivery approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Determining the activity of mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Mucosal immunology of the upper airways: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Exploiting dendritic cells to improve vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Sublingual vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

The role of adjuvants in the development of mucosal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Recent advances in vaccine adjuvants for systemic and mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.12.043

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42242848&oldid=1939770242"